483
Apitoria Pharma Private LimitedFDA 483 - Apitoria Pharma Private Limited - December 01, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Apitoria Pharma Private Limited, a sterile API manufacturer in J.N.Pharamacity, Telangana, India, revealed significant deficiencies in aseptic processing. Observations included inadequate airflow visualization studies for aseptic filling lines, a lack of environmental sampling to support cross-contamination controls, and an aseptic process simulation study that failed to assess worst-case challenge organisms.
Open in Dashboard
ID · 6f5e5d42-b274-40c8-a6ea-1599f903fa48